New cfiA variant and novel insertion sequence elements in carbapenem-resistant Bacteroides fragilis isolates from Korea

被引:25
作者
Roh, Kyoung Ho [2 ]
Kim, Sinyoung [3 ]
Kim, Chang-Ki [4 ]
Yum, Jong Hwa [5 ]
Kim, Myung Sook
Yong, Dongeun [1 ,3 ]
Jeong, Seok Hoon [3 ]
Lee, Kyungwon [3 ]
Kim, June Myung [6 ]
Chong, Yunsop [3 ]
机构
[1] Yonsei Univ, Coll Med, Dept Lab Med, Res Inst Bacterial Resistance, Seoul 120752, South Korea
[2] Korea Univ, Coll Med, Dept Lab Med, Seoul 136705, South Korea
[3] Yonsei Univ, Coll Med, Brain Korea Med Sci 21, Seoul 120752, South Korea
[4] Korean Inst TB, Seoul 137140, South Korea
[5] Dong Eui Univ, Dept Clin Lab Sci, Pusan 614714, South Korea
[6] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea
关键词
Bacteroides fragilis; cfiA(11); Novel IS elements; Metallo-beta-lactamase; METALLO-BETA-LACTAMASE; GENE CFIA; IMIPENEM RESISTANCE; STRAINS; EXPRESSION; CEPA; IDENTIFICATION; PURIFICATION; PREVALENCE; UPSTREAM;
D O I
10.1016/j.diagmicrobio.2009.11.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Of 276 nonduplicate Bacteroides fragilis clinical isolates recovered from 1997 to 2004, 3 were resistant to carbapenem. cepA and cfiA alleles were detected by polymerase chain reaction in 240 (87.0%) and 11 (4.0%) of the isolates, respectively. Insertion sequence (IS) elements were found only in the 3 carbapenem-resistant B. fragilis isolates, which produced metallo-beta-lactamase at a level detectable by UV spectrophotometry. Sequence analysis showed 1 new cfiA variant, cfiA(11), and 2 novel IS elements. The cfiA(11) gene revealed 5 amino acid substitutions compared to cfiA, with 97.6% amino acid identity. The transposase, terminal inverted repeat sequence, and target site duplication sequence of the 2 novel IS elements were unique. This study reconfirmed the correlation between ISs and carbapenem resistance in B. fragilis. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 25 条
[1]   BIOCHEMICAL-PROPERTIES AND PURIFICATION OF METALLO-BETA-LACTAMASE FROM BACTEROIDES-FRAGILIS [J].
BANDOH, K ;
MUTO, Y ;
WATANABE, K ;
KATOH, N ;
UENO, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :371-372
[2]   Analysis of cepA and other Bacteroides fragilis genes reveals a unique promoter structure [J].
Bayley, DP ;
Rocha, ER ;
Smith, CJ .
FEMS MICROBIOLOGY LETTERS, 2000, 193 (01) :149-154
[3]  
Citron DM, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P911
[4]   BETA-LACTAMASE-MEDIATED IMIPENEM RESISTANCE IN BACTEROIDES-FRAGILIS [J].
CUCHURAL, GJ ;
MALAMY, MH ;
TALLY, FP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :645-648
[5]   Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK [J].
Edwards, R ;
Hawkyard, CV ;
Garvey, MT ;
Greenwood, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :273-276
[6]   Distinctive outer membrane protein and lipopolysaccharide composition of Bacteroides fragilis strains that produce metallo-beta-lactamase [J].
Edwards, R ;
Greenwood, D .
ANAEROBE, 1997, 3 (04) :233-236
[7]   Update of the standard numbering scheme for class B β-lactamases [J].
Garau, G ;
García-Sáez, I ;
Bebrone, C ;
Anne, C ;
Mercuri, P ;
Galleni, M ;
Frère, JM ;
Dideberg, O .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2347-2349
[8]   Genetic determinants for cfxA expression in Bacteroides strains isolated from human infections [J].
Garcia, Nuria ;
Gutierrez, Gloria ;
Lorenzo, Maria ;
Garcia, Jose E. ;
Piriz, Segundo ;
Quesada, Alberto .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :942-947
[9]   Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis:: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes [J].
Gutacker, M ;
Valsangiacomo, C ;
Piffaretti, JC .
MICROBIOLOGY-SGM, 2000, 146 :1241-1254
[10]   PURIFICATION AND CHARACTERIZATION OF AN IMIPENEM HYDROLYZING METALLO-BETA-LACTAMASE FROM BACTEROIDES-FRAGILIS [J].
HEDBERG, M ;
EDLUND, C ;
LINDQVIST, L ;
RYLANDER, M ;
NORD, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (02) :105-113